FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2097671323> ?p ?o ?g. }

• W2097671323 endingPage "1670" @default.
• W2097671323 startingPage "1663" @default.
• W2097671323 abstract "The monoclonal antibody cetuximab (IMC-225, Erbitux) inhibits epidermal growth factor receptor (EGFR) signaling and has been approved for metastatic colon cancer therapy. However, to achieve effective titers, passive antibody therapies must be repeatedly administered over long periods. To overcome this limitation, we aimed to generate a vaccine inducing continuously available cetuximab-like antibodies in vivo using the mimotope approach.We used the phage display technique to identify four peptides structurally mimicking the cetuximab epitope. We coupled two of these peptides to an immunogenic carrier protein, and we vaccinated four groups (n = 8) of BALB/c mice intraperitoneally with 10 microg of the mimotope conjugates, a control peptide conjugate, or the carrier protein alone. We assessed antibody-dependent cellular cytotoxicity and complement-dependent cytotoxicity mediated by the induced antibodies against EGFR-overexpressing human A431 carcinoma cells. We then tested receptor internalization capacity of the induced antibodies with fluorescently labeled EGFR, and we assayed their growth inhibitory potential toward A431 cells with a [3H]thymidine proliferation assay.Mimotope-induced antibodies recognized EGFR, and both types of antibody-mediated cytotoxic effects were elicited by these antibodies. In both cellular cytotoxicity assays, the mimotope-induced antibodies exhibited specific lysis of more than 50%. The induced antibodies caused internalization of the receptor from the cell surface into endocytic vesicles and inhibited growth of EGFR-expressing cells to a similar extent as cetuximab [67% (95% confidence interval {CI} = 55% to 79%) and 69% (95% CI = 55% to 84%), respectively].Epitope-specific immunization is feasible for active anti-EGFR immunotherapy. The in vitro biologic features of mimotope-induced antibodies are similar to those of the monoclonal antibody cetuximab." @default.
• W2097671323 created "2016-06-24" @default.
• W2097671323 creator A5013554446 @default.
• W2097671323 creator A5050310993 @default.
• W2097671323 creator A5073132442 @default.
• W2097671323 creator A5077961608 @default.
• W2097671323 creator A5090061936 @default.
• W2097671323 creator A5091490797 @default.
• W2097671323 date "2005-11-16" @default.
• W2097671323 modified "2023-10-18" @default.
• W2097671323 title "Vaccination With Cetuximab Mimotopes and Biological Properties of Induced Anti–Epidermal Growth Factor Receptor Antibodies" @default.
• W2097671323 cites W1559176388 @default.
• W2097671323 cites W1570686199 @default.
• W2097671323 cites W1570981769 @default.
• W2097671323 cites W1964321121 @default.
• W2097671323 cites W1981608739 @default.
• W2097671323 cites W1994501723 @default.
• W2097671323 cites W1996888234 @default.
• W2097671323 cites W2012629036 @default.
• W2097671323 cites W2014421076 @default.
• W2097671323 cites W2028024981 @default.
• W2097671323 cites W2032806769 @default.
• W2097671323 cites W2039633811 @default.
• W2097671323 cites W2051120695 @default.
• W2097671323 cites W2064047613 @default.
• W2097671323 cites W2070360032 @default.
• W2097671323 cites W2071378581 @default.
• W2097671323 cites W2072698880 @default.
• W2097671323 cites W2079238835 @default.
• W2097671323 cites W2081384426 @default.
• W2097671323 cites W2084429764 @default.
• W2097671323 cites W2102629093 @default.
• W2097671323 cites W2144153233 @default.
• W2097671323 cites W2149051154 @default.
• W2097671323 cites W24565741 @default.
• W2097671323 cites W4254324976 @default.
• W2097671323 doi "https://doi.org/10.1093/jnci/dji373" @default.
• W2097671323 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16288119" @default.
• W2097671323 hasPublicationYear "2005" @default.
• W2097671323 type Work @default.
• W2097671323 sameAs 2097671323 @default.
• W2097671323 citedByCount "78" @default.
• W2097671323 countsByYear W20976713232012 @default.
• W2097671323 countsByYear W20976713232013 @default.
• W2097671323 countsByYear W20976713232014 @default.
• W2097671323 countsByYear W20976713232015 @default.
• W2097671323 countsByYear W20976713232016 @default.
• W2097671323 countsByYear W20976713232017 @default.
• W2097671323 countsByYear W20976713232018 @default.
• W2097671323 countsByYear W20976713232019 @default.
• W2097671323 countsByYear W20976713232020 @default.
• W2097671323 countsByYear W20976713232022 @default.
• W2097671323 countsByYear W20976713232023 @default.
• W2097671323 crossrefType "journal-article" @default.
• W2097671323 hasAuthorship W2097671323A5013554446 @default.
• W2097671323 hasAuthorship W2097671323A5050310993 @default.
• W2097671323 hasAuthorship W2097671323A5073132442 @default.
• W2097671323 hasAuthorship W2097671323A5077961608 @default.
• W2097671323 hasAuthorship W2097671323A5090061936 @default.
• W2097671323 hasAuthorship W2097671323A5091490797 @default.
• W2097671323 hasConcept C109316439 @default.
• W2097671323 hasConcept C115085202 @default.
• W2097671323 hasConcept C139770010 @default.
• W2097671323 hasConcept C153911025 @default.
• W2097671323 hasConcept C159654299 @default.
• W2097671323 hasConcept C170493617 @default.
• W2097671323 hasConcept C195616568 @default.
• W2097671323 hasConcept C202751555 @default.
• W2097671323 hasConcept C203014093 @default.
• W2097671323 hasConcept C2779438470 @default.
• W2097671323 hasConcept C2779998722 @default.
• W2097671323 hasConcept C40677261 @default.
• W2097671323 hasConcept C502942594 @default.
• W2097671323 hasConcept C542903549 @default.
• W2097671323 hasConcept C55493867 @default.
• W2097671323 hasConcept C86803240 @default.
• W2097671323 hasConcept C9365378 @default.
• W2097671323 hasConceptScore W2097671323C109316439 @default.
• W2097671323 hasConceptScore W2097671323C115085202 @default.
• W2097671323 hasConceptScore W2097671323C139770010 @default.
• W2097671323 hasConceptScore W2097671323C153911025 @default.
• W2097671323 hasConceptScore W2097671323C159654299 @default.
• W2097671323 hasConceptScore W2097671323C170493617 @default.
• W2097671323 hasConceptScore W2097671323C195616568 @default.
• W2097671323 hasConceptScore W2097671323C202751555 @default.
• W2097671323 hasConceptScore W2097671323C203014093 @default.
• W2097671323 hasConceptScore W2097671323C2779438470 @default.
• W2097671323 hasConceptScore W2097671323C2779998722 @default.
• W2097671323 hasConceptScore W2097671323C40677261 @default.
• W2097671323 hasConceptScore W2097671323C502942594 @default.
• W2097671323 hasConceptScore W2097671323C542903549 @default.
• W2097671323 hasConceptScore W2097671323C55493867 @default.
• W2097671323 hasConceptScore W2097671323C86803240 @default.
• W2097671323 hasConceptScore W2097671323C9365378 @default.
• W2097671323 hasIssue "22" @default.
• W2097671323 hasLocation W20976713231 @default.
• W2097671323 hasLocation W20976713232 @default.
• W2097671323 hasOpenAccess W2097671323 @default.

• next